Low-value care refers to treatments or services that don’t offer real value for patients, and in some cases may even cause harm. Low-value care is a pervasive problem in the U. S., with as much as $340 billion being spent on low-value or unnecessary care alone.[i] With health care spending projected to reach nearly 20% of GDP in the next decade,[ii] eliminating low-value care and the associated costs to our health care system is becoming increasingly critical.
How are organizations tackling this problem, and what can be done? During a webinar held on August 5 hosted by Going Below The Surface partner AMGA, AMGA members shared case studies on how their organizations are reducing low-value care. They also introduced the Going Below The Surface Roadmap for Addressing Low-Value Care and shared how organizations can use this guide for developing a strategy to address low-value care.
Speakers include:
1. Jerry Penso, MD, MBA, President and Chief Executive Officer, AMGA
2. Robert W. Dubois, MD, PhD, Chief Science Officer and Executive Vice President, National Pharmaceutical Council
3. Beth Averbeck, MD, Senior Medical Director, Primary Care, HealthPartners Care Group
4. Mark Briesacher, MD, Senior Vice President, Chief Physician Officer & President, Intermountain Medical Group